bioAffinity's CyPath Lung test helps avoid biopsy in elderly patient case

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. CRWD
2. AAPL
3. LITE
4. PLTR
5. REGN
6. ABBV
7. MRVL
8. CL
9. CHKP
10. SPY

Go back to bioAffinity's CyPath Lung test helps avoid biopsy in elderly patient case

New Case Study Highlights Ability of bioAffinity Technologies’ CyPath® Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer

February 19, 2026 11:00 AM EST

CyPath® Lung test supported recommendation for surveillance strategy, rather than subjecting elderly patient to an invasive, risky and costly biopsy procedure

Despite a suspicious nodule during a low-dose CT scan, a repeat scan showed no nodules in the lungs, validating the decision made with CyPath® Lungs results

Noninvasive CyPath® Lung test has shown 92% sensitivity, 87% specificity and 88% accuracy for detecting lung cancer in small nodules less than 2 centimeters

SAN ANTONIO, Texas--(BUSINESS... More